Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol.

Zhao XJ, Dong Q, Bindas J, Piganelli JD, Magill A, Reiser J, Kolls JK.

J Immunol. 2008 Sep 1;181(5):3049-56.

2.

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.

Osei-Hyiaman D, Liu J, Zhou L, Godlewski G, Harvey-White J, Jeong WI, Bátkai S, Marsicano G, Lutz B, Buettner C, Kunos G.

J Clin Invest. 2008 Sep;118(9):3160-9. doi: 10.1172/JCI34827.

3.

Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell line.

Puljak L, Parameswara V, Dolovcak S, Waldrop SL, Emmett D, Esser V, Fitz JG, Kilic G.

Exp Cell Res. 2008 Jun 10;314(10):2100-9. doi: 10.1016/j.yexcr.2008.03.002. Epub 2008 Mar 12.

4.

Internalization and desensitization of adenosine receptors.

Klaasse EC, Ijzerman AP, de Grip WJ, Beukers MW.

Purinergic Signal. 2008 Mar;4(1):21-37. doi: 10.1007/s11302-007-9086-7. Epub 2007 Nov 13.

5.

Guide to Receptors and Channels (GRAC), 3rd edition.

Alexander SP, Mathie A, Peters JA.

Br J Pharmacol. 2008 Mar;153 Suppl 2:S1-209. doi: 10.1038/sj.bjp.0707746. No abstract available.

6.

Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.

Jeong WI, Osei-Hyiaman D, Park O, Liu J, Bátkai S, Mukhopadhyay P, Horiguchi N, Harvey-White J, Marsicano G, Lutz B, Gao B, Kunos G.

Cell Metab. 2008 Mar;7(3):227-35. doi: 10.1016/j.cmet.2007.12.007.

7.

Ecto-5'-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis.

Peng Z, Fernandez P, Wilder T, Yee H, Chiriboga L, Chan ES, Cronstein BN.

FASEB J. 2008 Jul;22(7):2263-72. doi: 10.1096/fj.07-100685. Epub 2008 Feb 8.

PMID:
18263696
8.

Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line.

Shimizu A, Takamura T, Matsuzawa N, Nakamura S, Nabemoto S, Takeshita Y, Misu H, Kurita S, Sakurai M, Yokoyama M, Zen Y, Sasaki M, Nakanuma Y, Kaneko S.

Metabolism. 2007 Nov;56(11):1478-85.

PMID:
17950097
9.
10.

Alcohol-induced steatosis in liver cells.

Donohue TM Jr.

World J Gastroenterol. 2007 Oct 7;13(37):4974-8. Review.

11.
12.

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.

Gary-Bobo M, Elachouri G, Gallas JF, Janiak P, Marini P, Ravinet-Trillou C, Chabbert M, Cruccioli N, Pfersdorff C, Roque C, Arnone M, Croci T, Soubrié P, Oury-Donat F, Maffrand JP, Scatton B, Lacheretz F, Le Fur G, Herbert JM, Bensaid M.

Hepatology. 2007 Jul;46(1):122-9.

PMID:
17526015
13.

The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.

Serrano A, Del Arco I, Javier Pavón F, Macías M, Perez-Valero V, Rodríguez de Fonseca F.

Neuropharmacology. 2008 Jan;54(1):226-34. Epub 2007 Mar 24.

PMID:
17467748
14.

Adenosine, an endogenous distress signal, modulates tissue damage and repair.

Fredholm BB.

Cell Death Differ. 2007 Jul;14(7):1315-23. Epub 2007 Mar 30. Review.

15.

A1 adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents.

Dhalla AK, Wong MY, Voshol PJ, Belardinelli L, Reaven GM.

Am J Physiol Endocrinol Metab. 2007 May;292(5):E1358-63. Epub 2007 Jan 16.

16.

Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid.

Dhalla AK, Santikul M, Smith M, Wong MY, Shryock JC, Belardinelli L.

J Pharmacol Exp Ther. 2007 Apr;321(1):327-33. Epub 2007 Jan 4.

17.

Enhanced mast cell activation in mice deficient in the A2b adenosine receptor.

Hua X, Kovarova M, Chason KD, Nguyen M, Koller BH, Tilley SL.

J Exp Med. 2007 Jan 22;204(1):117-28. Epub 2007 Jan 2. Erratum in: J Exp Med. 2007 Apr 16;204(4):963.

19.

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.

Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K.

N Engl J Med. 2006 Nov 30;355(22):2297-307.

20.

Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells.

Hashmi AZ, Hakim W, Kruglov EA, Watanabe A, Watkins W, Dranoff JA, Mehal WZ.

Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G395-401. Epub 2006 Oct 19.

Supplemental Content

Support Center